Wellington Management Group LLP 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-09 1:26 pm Sale | 2023-10-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Wellington Management Group LLP | 2,200,757 3.950% | -3,522,374 (-61.55%) | Filing |
| 2023-04-10 09:06 am Purchase | 2023-03-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Wellington Management Group LLP | 5,723,131 10.350% | 260,474 (+4.77%) | Filing |
| 2023-02-06 2:43 pm Purchase | 2022-12-30 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Wellington Management Group LLP | 5,462,657 9.940% | 314,091 (+6.10%) | Filing |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Wellington Management Group LLP | 5,148,566 9.480% | -2,728,804 (-34.64%) | Filing |